GW&K Investment Management LLC Buys 133,379 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)

GW&K Investment Management LLC raised its stake in Medpace Holdings, Inc. (NASDAQ:MEDP) by 93.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 275,460 shares of the company’s stock after acquiring an additional 133,379 shares during the period. Medpace makes up 0.8% of GW&K Investment Management LLC’s portfolio, making the stock its 18th largest holding. GW&K Investment Management LLC owned approximately 0.89% of Medpace worth $91,516,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of MEDP. R Squared Ltd bought a new stake in shares of Medpace in the fourth quarter worth about $30,000. Stone House Investment Management LLC purchased a new position in Medpace during the 3rd quarter valued at approximately $33,000. Ashton Thomas Securities LLC bought a new stake in Medpace in the 3rd quarter worth approximately $37,000. Capital Performance Advisors LLP purchased a new stake in shares of Medpace during the 3rd quarter worth approximately $46,000. Finally, True Wealth Design LLC raised its holdings in shares of Medpace by 16,800.0% during the 3rd quarter. True Wealth Design LLC now owns 169 shares of the company’s stock worth $56,000 after acquiring an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 77.98% of the company’s stock.

Analysts Set New Price Targets

Separately, Robert W. Baird raised their target price on shares of Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $381.44.

Medpace Stock Performance

NASDAQ:MEDP opened at $326.11 on Friday. The firm has a market capitalization of $9.94 billion, a PE ratio of 25.82, a PEG ratio of 3.81 and a beta of 1.36. The stock’s fifty day moving average is $342.86 and its 200 day moving average is $346.05. Medpace Holdings, Inc. has a fifty-two week low of $302.01 and a fifty-two week high of $459.77.

Medpace (NASDAQ:MEDP) last announced its earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. Equities analysts forecast that Medpace Holdings, Inc. will post 12.29 EPS for the current year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.